NIH Funding Shifts With Disease Lobbying, Study Suggests

摘要

The growing power and influence of disease lobbying groups over the past 2 decades have dramatically reshaped the priorities of the U.S. National Institutes of Health (NIH), according to a new analysis. The study, which has drawn some skepticism, finds that the more money a group spent on lobbying, the more NIH boosted its spending on that disease. The findings "suggest that advocacy has an impressive payoff," says sociologist Steven Epstein of Northwestern University in Evanston, Illinois, who did not participate in the study.